[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Malihe Mahmoudinia\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":68},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,45],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":29,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":4},"100593202","comparison-of-two-protocols-in-frozen-embryo-transfer-100593202",false,"NCT07003373","Comparison of Two Protocols in Frozen Embryo Transfer","Comparison of the Pregnancy Outcomes of Frozen Embryo Transfer in the Natural Cycle vs. Artificial Cycle","Inclusion Criteria:\n\nRegular menstrual cycles\n\nMaternal age between 18 and 42 years\n\nNormal intrauterine cavity confirmed by pretreatment ultrasound or hysteroscopy\n\nBody Mass Index (BMI) less than 30 kg\u002Fm²\n\nNo ovulation disorders\n\nExclusion Criteria:\n\nNo embryos available for transfer (no embryo thawing)\n\nWithdrawal of patient consent to continue treatment\n\nFailure of dominant follicle development (in natural cycle group)\n\nInadequate endometrial response for transfer\n\nNo endometriosis grade 3 or higher\n\nThe participant provided written informed consent",true,"FEMALE","18 Years","42 Years",{"count":21,"type":22},112,"ESTIMATED","INTERVENTIONAL",[25],"NA","This randomized clinical trial evaluates two different endometrial preparation protocols-hormone replacement therapy (HRT) and natural cycle-for frozen embryo transfer (FET) in infertile women undergoing assisted reproductive technology (ART). The goal is to compare implantation, clinical pregnancy, and ongoing pregnancy outcomes.",[28],"IVF Outcomes",[30,31,32],"Natural cycle","Artificial cycle","Frozen embryo transfer","NOT_YET_RECRUITING","2025-05-25",{"date":36,"type":37},"2025-06-04","ACTUAL",{"date":39,"type":22},"2025-07-05",{"date":41,"type":22},"2026-07-05",{"name":43,"class":44},"Malihe Mahmoudinia","OTHER",{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":16,"sex":17,"minAge":52,"maxAge":53,"enrollmentInfo":54,"targetDuration":4,"studyType":23,"phases":56,"briefSummary":57,"conditions":58,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":64,"completionDateStruct":65,"leadSponsor":67,"locationsCount":4},"100575246","evaluation-of-pregnancy-outcome-with-usage-of-drug-free-in-vitro-activation-of-follicles-ovary-100575246","NCT06769789","Evaluation of Pregnancy Outcome with Usage of Drug-free In-vitro Activation of Follicles Ovary","Evaluation of Pregnancy Outcome in Poor Responder Patients in IVF Cycle with Usage of Drug-free In-vitro Activation of Follicles Ovary","Inclusion Criteria:\n\n* Women under 35 years of age who have one of the following characteristics:\n\nOr poor response to gonadotropins in a previous IVF cycle (fewer than 3 oocytes in a previous IVF cycle)\n\nOr ovarian reserve test AMH less than 1.1\n\nExclusion Criteria:\n\n* Unwillingness to continue working with the researcher during the procedure","21 Years","35 Years",{"count":55,"type":22},23,[25],"This study is the pilot study to evaluate the effect of Drug-free in vitro activation to improve the outcomes of IVF in poor responder women",[59,60],"Infertility (IVF Patients)","Infertile Females or Females with Ovarian Insufficiency","2025-01-07",{"date":63,"type":37},"2025-01-10",{"date":63,"type":22},{"date":66,"type":22},"2027-01-10",{"name":43,"class":44},""]